| CASE REPORT |
|
| Year : 2016 | Volume
: 31
| Issue : 2 | Page : 128-130 |
|
|
Role of fluorine-18-fluorodeoxyglucose positron emission tomography-computed tomography in management of pulmonary mucoepidermoid carcinomas and review of literature
Arvind Krishnamurthy1, Vijayalakshmi Ramshankar2, Urmila Majhi3
1 Department of Surgical Oncology, Pathology Cancer Institute, Chennai, Tamil Nadu, India
2 Department of Preventive Oncology, Pathology Cancer Institute, Chennai, Tamil Nadu, India
3 Pathology Cancer Institute, Chennai, Tamil Nadu, India
Correspondence Address:
Arvind Krishnamurthy
Cancer Institute (WIA), 38, Sardar Patel Rood, Adyar, Chennai - 600 036, Tamil Nadu
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0972-3919.178264
|
|
|
Pulmonary mucoepidermoid carcinoma (PMEC) is a rare tumor of bronchial gland origin with a striking resemblance to MEC of the salivary glands. The World Health Organization classifies PMECs as "salivary gland type" tumors along with pulmonary adenoid cystic carcinomas and epimyoepithelial lung carcinomas. Their description in literature is largely limited to a few case series/case reports. Further, the experience of imaging in these tumors with fluorine-18 fluorodeoxyglucose positron emission tomography-computed tomography ( 18 F-FDG PET-CT) is also limited and evolving largely due to rarity of PMEC. We recently managed an interesting case of a PMEC and reviewed the literature surrounding this rare tumor with an emphasis on the role of 18 F-FDG PET-CT in its management. An 18 F-FDG PET-CT appears to be a useful imaging modality for predicting the tumor grade of patients with PMECs; further, there is emerging data to suggest the role of 18 F-FDG PET-CT for predicting the long-term prognosis of patients with PMEC. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
